UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of dermatology (1951), ISSN 0007-0963, 04/2005, Volume 152, Issue 4, pp. 597 - 615
ciclosporin | methotrexate | fumaric acid esters | phototherapy | psoriasis | retinoids | Ciclosporin | Retinoids | Psoriasis | Methotrexate | Fumaric acid esters | Phototherapy | Life Sciences & Biomedicine | Dermatology | Science & Technology | Biological and medical sciences | Medical sciences | Psoriasis. Parapsoriasis. Lichen | PUVA Therapy - adverse effects | Risk Assessment - methods | Dermatologic Agents - administration & dosage | Humans | Fumarates - administration & dosage | Photosensitizing Agents - adverse effects | Dermatologic Agents - adverse effects | Photosensitizing Agents - administration & dosage | Retinoids - administration & dosage | Retinoids - adverse effects | Ficusin - adverse effects | Immunosuppressive Agents - administration & dosage | Psoriasis - therapy | Psoriasis - drug therapy | Administration, Oral | Psoriasis - radiotherapy | Fumarates - adverse effects | Ficusin - administration & dosage | Ultraviolet Therapy - methods | Methotrexate - adverse effects | PUVA Therapy - methods | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Ultraviolet Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Methotrexate - administration & dosage | Chronic Disease | Index Medicus
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 03/2011, Volume 164, Issue 3, pp. 465 - 472
Life Sciences & Biomedicine | Dermatology | Science & Technology | Biological and medical sciences | Medical sciences | Lupus Erythematosus, Cutaneous - chemically induced | Proton Pump Inhibitors - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Lupus Erythematosus, Cutaneous - immunology | Lupus Erythematosus, Cutaneous - pathology | Male | Histamine Antagonists - adverse effects | Antihypertensive Agents - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anticonvulsants - adverse effects | Antineoplastic Agents - adverse effects | Drug-Related Side Effects and Adverse Reactions | Ultraviolet Therapy - adverse effects | Biological Products - adverse effects | Female | Immunologic Factors - adverse effects | Autoimmunity | Lupus | Medical colleges | Systemic lupus erythematosus | Autoantibodies | Analysis | Index Medicus
Journal Article
Dermatologic clinics, ISSN 0733-8635, 01/2015, Volume 33, Issue 1, pp. 79 - 89
UV-B | UV mode of action | PUVA | Narrow band | Broad band | Life Sciences & Biomedicine | Dermatology | Science & Technology | PUVA Therapy - adverse effects | Photochemotherapy - adverse effects | Psoriasis - drug therapy | Reactive Oxygen Species | Photosensitizing Agents - therapeutic use | Apoptosis - radiation effects | Keratinocytes - radiation effects | Humans | Psoriasis - radiotherapy | T-Lymphocytes - radiation effects | Antibodies, Monoclonal - therapeutic use | Combined Modality Therapy | Dermatologic Agents - therapeutic use | Urocanic Acid - metabolism | Retinoids - therapeutic use | Ultraviolet Therapy - adverse effects | Ultraviolet Therapy - economics | DNA Damage - radiation effects
Journal Article
Cancer cell, ISSN 1535-6108, 05/2016, Volume 29, Issue 5, pp. 622 - 637
Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Smoking - adverse effects | Carcinoma, Squamous Cell - etiology | Genetic Predisposition to Disease - genetics | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Carcinoma, Squamous Cell - therapy | Models, Genetic | Mutation | Alcohol Drinking - adverse effects | Infection - complications | Ultraviolet Rays - adverse effects | Medical colleges | Squamous cell carcinoma | Genetic aspects | Analysis | Cancer | Epigenetic inheritance | Mortality | Index Medicus
Journal Article
Journal of dermatology, ISSN 0385-2407, 10/2016, Volume 43, Issue 10, pp. 1117 - 1145
evidence‐based medicine | clinical practice guideline | treatment | atopic dermatitis | diagnosis | evidence-based medicine | Life Sciences & Biomedicine | Dermatology | Science & Technology | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Dermatologic Agents - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Dermatitis, Atopic - classification | Dermatologic Agents - therapeutic use | Administration, Cutaneous | Dermatitis, Atopic - therapy | Histamine Antagonists - therapeutic use | Dermatologic Agents - adverse effects | Histamine Antagonists - adverse effects | Dermatitis, Atopic - diagnosis | Anti-Inflammatory Agents - adverse effects | Pruritus - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Ointments | Glucocorticoids - adverse effects | Patient Education as Topic | Tacrolimus - administration & dosage | Severity of Illness Index | Administration, Oral | Japan | Histamine Antagonists - administration & dosage | Evidence-Based Medicine | Tacrolimus - adverse effects | Ultraviolet Therapy - methods | Tacrolimus - therapeutic use | Quality of Life | Diet Therapy - methods | Immunosuppressive Agents - adverse effects | Dermatitis, Atopic - blood | Patient Compliance | Usage | Tacrolimus | Atopic dermatitis | Formulae, receipts, prescriptions | Dermatologic agents | Pruritus | Prescription drugs | Clinical medicine | Dermatitis | Index Medicus
Journal Article